Peringkat dalam Saham
#26169
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Kapitalisasi Pasar
$42.88M
Perubahan (1 tahun)
-18.85%
Perdagangan Molecure S.A. (MOC)
Harga MOC dengan kapitalisasi pasar B
Kapitalisasi pasar dari Molecure S.A.(MOC)
Kapitalisasi Pasar: $42.88M
Per August 2026, Molecure S.A. memiliki kapitalisasi pasar sebesar $42.88M. Ini menjadikan Molecure S.A. sebagai perusahaan 26169th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Molecure S.A. dari 2018 hingga 2026
MOC dibandingkan dengan 5 teratas stocks paling populer
| Harga MOC |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.242T
|
+12,225,855.89%
|
|
|
|
|
$4.649T
|
+10,842,612.07%
|
|
|
|
|
$4.111T
|
+9,588,689.23%
|
|
|
|
|
$3.572T
|
+8,331,273.64%
|
|
|
|
|
$2.811T
|
+6,556,860.44%
|
